Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

Risks include bleeding, infection, voice changes, and thyroid hormone imbalances. Our team takes measures to minimize these risks and ensure a successful outcome.

The TB GOLD Test is an advanced diagnostic tool that uses an interferon-gamma release assay (IGRA) to detect latent tuberculosis infection.

Unlike the tuberculin skin test (TST), the TB GOLD Test does not require a return visit for reading and provides more accurate results by measuring the immune response to TB-specific antigens.

No special preparation is required. You can eat and drink normally before the test, but inform your healthcare provider about any medications or recent illnesses.

Results are typically available within 2 to 7 days after the sample is analyzed in the laboratory.

The TB GOLD Test helps accurately diagnose latent TB infection, which is crucial for preventing the progression to active TB and ensuring appropriate treatment and management.